Am J Gastroenterol10 Apr 2025
A nationwide study in Japan reveals that the risk of adverse events (AEs) during colorectal endoscopic submucosal dissection (ESD) escalates significantly in older adults, particularly those aged 85 and above. Among 143,925 patients, AEs were recorded at 5.3% for ages 60-64, rising to 9.2% for…
HPB & Spleen10 Apr 2025
Long-term follow-up of 40 patients treated for external pancreatic fistulas revealed a 100% closure rate after rendezvous internalization treatment, with an average closure time of 20 days. Complication rates were modest, including post-procedural acute pancreatitis (12.5%) and minor bleeding (7.5%). During a median follow-up of…
Am J Gastroenterol3 Apr 2025
A multicenter trial revealed that spray coagulation mode endoscopic submucosal dissection (scm-esd) significantly improved completion rates for treating early gastric neoplasms without the use of hemostatic forceps, achieving 83.1% versus 13.8% for conventional forced coagulation mode (fcm-esd). Procedure time and adverse event rates were comparable…
Gastrointest Endosc2 Apr 2025
A global expert consensus defined standardized practices for Endoscopic Sleeve Gastroplasty (ESG) utilizing a modified Delphi method. Six experts, after three survey rounds, achieved 100% agreement on six cognitive skill statements and high consensus on 21 technical skill statements. Key procedural elements emphasized were starting…
Therap Adv Gastroenterol29 Mar 2025
Higher stages of the OLGA and OLGIM staging systems significantly correlate with an elevated risk of developing high-grade dysplasia (HGD) and gastric cancer (GC). A systematic review and meta-analysis of eight prospective cohort studies found that moving from OLGA/OLGIM categories 0-II to III-IV notably increases…
Surg Laparosc Endosc Percutan Tech27 Mar 2025
A systematic review and meta-analysis of endoscopic ultrasound-guided pancreatic duct drainage (EUS-PD) revealed significant effectiveness, with technical success at 89% and clinical success at 88%. Examining 27 trials involving 902 patients, the study also noted a 17% rate of adverse events, primarily post-EUS-PD acute pancreatitis…
Expert Rev Gastroenterol Hepatol25 Mar 2025
EUS-guided gallbladder drainage (EUS-GBD) is emerging as a safe, effective solution for managing acute cholecystitis in patients unfit for surgery. Recent findings indicate improved technical and clinical outcomes, especially with the use of lumen-apposing metal stents, which facilitate direct gallbladder inspection. The study emphasizes the…
HPB & Spleen16 Mar 2025
Significant advancements in endoscopic techniques for managing malignant biliary and gastric outlet obstruction in pancreatic cancer patients provide promising alternatives to traditional surgical bypass. Emerging evidence suggests that endoscopic ultrasound-guided methods, including biliary drainage and gastroenterostomy, may outperform conventional approaches, addressing symptom relief more effectively.…
Int J Surg13 Mar 2025
A multicenter trial demonstrated that radiation-emitting metallic stents (REMS) combined with hepatic arterial infusion chemotherapy (HAIC) significantly outperformed self-expandable metallic stents (SEMS) in patients with unresectable Bismuth type III or IV perihilar cholangiocarcinoma. The median overall survival was 10.2 months for REMS compared to 6.7…
Gastrointest Endosc11 Mar 2025
A prospective multicenter study evaluated the effectiveness of endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) in diagnosing autoimmune pancreatitis (AIP) using the International Consensus Diagnostic Criteria (ICDC). Results showed that EUS-FNB improved diagnostic levels in 92.3% of suspected AIP patients, with a diagnostic accuracy of 94.2%. The…